share_log

IRhythm Technologies Insiders Sell US$4.0m Of Stock, Possibly Signalling Caution

IRhythm Technologies Insiders Sell US$4.0m Of Stock, Possibly Signalling Caution

iRhythm Technologies 內部人士出售了 400 萬美元的股票,可能表示謹慎行事
Simply Wall St ·  2023/10/26 15:32

Over the past year, many iRhythm Technologies, Inc. (NASDAQ:IRTC) insiders sold a significant stake in the company which may have piqued investors' interest. Knowing whether insiders are buying is usually more helpful when evaluating insider transactions, as insider selling can have various explanations. However, shareholders should take a deeper look if several insiders are selling stock over a specific time period.

在過去的一年裡,許多人IRhythm技術公司納斯達克(Sequoia Capital:IRTC)內部人士出售了該公司的大量股份,這可能激起了投資者的興趣。在評估內幕交易時,瞭解內幕人士是否在買入通常更有幫助,因為內幕交易可能有各種解釋。然而,如果有幾個內部人士在特定時間段內出售股票,股東們應該更深入地研究一下。

Although we don't think shareholders should simply follow insider transactions, we would consider it foolish to ignore insider transactions altogether.

儘管我們不認為股東應該簡單地追隨內幕交易,但我們認為完全忽視內幕交易是愚蠢的。

See our latest analysis for iRhythm Technologies

查看我們對iRhythm Technologies的最新分析

iRhythm Technologies Insider Transactions Over The Last Year

IRhythm Technologies去年的內幕交易

In the last twelve months, the biggest single sale by an insider was when the President, Quentin Blackford, sold US$1.6m worth of shares at a price of US$123 per share. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. The good news is that this large sale was at well above current price of US$75.44. So it is hard to draw any strong conclusion from it.

在過去的12個月裡,內部人士最大的一筆出售是總裁,昆汀·布萊克福德,以每股123美元的價格出售了價值160萬美元的股票。雖然我們通常不喜歡看到內幕出售,但如果以更低的價格出售,人們更擔心的是。好消息是,這筆大筆交易的價格遠遠高於目前75.44美元的價格。因此,很難從中得出任何強有力的結論。

Insiders in iRhythm Technologies didn't buy any shares in the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

IRhythm Technologies的內部人士去年沒有購買任何股票。你可以在下面看到過去12個月(由公司和個人)進行的內幕交易的直觀描述。如果你點擊圖表,你可以看到所有的個人交易,包括股票價格、個人和日期!

insider-trading-volume
NasdaqGS:IRTC Insider Trading Volume October 26th 2023
NasdaqGS:IRTC內幕交易量2023年10月26日

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

對於那些想要找到贏得投資免費最近有內幕收購的不斷增長的公司名單可能就是合適的選擇。

iRhythm Technologies Insiders Are Selling The Stock

IRhythm Technologies內部人士正在出售股票

Over the last three months, we've seen significant insider selling at iRhythm Technologies. In total, insiders sold US$341k worth of shares in that time, and we didn't record any purchases whatsoever. In light of this it's hard to argue that all the insiders think that the shares are a bargain.

在過去的三個月裡,我們看到了iRhythm Technologies的大量內幕銷售。在此期間,內部人士總共賣出了價值341,000美元的股票,我們沒有記錄任何買入。有鑒於此,很難辯稱所有內部人士都認為這些股票很划算。

Insider Ownership

內部人持股

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Insiders own 0.6% of iRhythm Technologies shares, worth about US$15m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

我喜歡看內部人士在一家公司持有多少股份,以幫助我瞭解他們與內部人士的關係。內部人持股比例較高往往會讓公司領導層更加關注股東利益。內部人士擁有iRhythm Technologies 0.6%的股份,價值約1500萬美元。雖然這是一個強大但並不突出的內部人持股水準,但這足以表明管理層和小股東之間的某種一致性。

So What Does This Data Suggest About iRhythm Technologies Insiders?

那麼,這些數據對iRhythm Technologies的內部人士有什麼啟示呢?

Insiders haven't bought iRhythm Technologies stock in the last three months, but there was some selling. Looking to the last twelve months, our data doesn't show any insider buying. While insiders do own shares, they don't own a heap, and they have been selling. We'd practice some caution before buying! So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. While conducting our analysis, we found that iRhythm Technologies has 2 warning signs and it would be unwise to ignore them.

過去三個月,內部人士沒有買入iRhythm Technologies的股票,但出現了一些拋售。展望過去12個月,我們的數據並未顯示有任何內部人士買入。雖然內部人士確實持有股票,但他們並不擁有大量股份,而且他們一直在拋售股票。我們會在購買之前練習一些謹慎的做法!因此,雖然瞭解內部人士在買入或賣出方面做了什麼是有幫助的,但瞭解一家特定公司面臨的風險也是有幫助的。在進行分析時,我們發現iRhythm Technologies2個個警告標誌忽視它們是不明智的。

Of course iRhythm Technologies may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

當然了IRhythm Technologies可能不是買入的最佳股票那就是。所以你可能想看看這個免費匯集了高質量的公司.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前只處理公開市場交易和私下處置直接權益,而不處理衍生工具交易或間接權益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫.或者,也可以給編輯組發電子郵件,地址是暗示Wallst.com。
本文由Simply Wall St.撰寫,具有概括性.我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議.它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況.我們的目標是為您帶來由基本面數據驅動的長期重點分析.請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內.Simply Wall St.對上述任何一隻股票都沒有持倉.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論